These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15262429)

  • 1. DNA sequence copy number aberrations in prostate cancers: a comparison of comparative genomic hybridization data between Japan and European countries.
    Matsuda K; Matsuyama H; Hara T; Yoshihiro S; Oga A; Kawauchi S; Furuya T; Izumi H; Naito K; Sasaki K
    Cancer Genet Cytogenet; 2004 Jul; 152(2):119-23. PubMed ID: 15262429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
    Visakorpi T; Kallioniemi AH; Syvänen AC; Hyytinen ER; Karhu R; Tammela T; Isola JJ; Kallioniemi OP
    Cancer Res; 1995 Jan; 55(2):342-7. PubMed ID: 7529134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal changes during development and progression of prostate adenocarcinomas.
    Zitzelsberger H; Engert D; Walch A; Kulka U; Aubele M; Höfler H; Bauchinger M; Werner M
    Br J Cancer; 2001 Jan; 84(2):202-8. PubMed ID: 11161378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Array-based genomic analysis of screen-detected Gleason score 6 and 7 prostatic adenocarcinomas.
    Postma R; van Marion R; van Duin M; Vissers KJ; Wink JC; Schröder FH; Tanke HJ; Szuhai K; van der Kwast TH; van Dekken H
    Anticancer Res; 2006; 26(2A):1193-200. PubMed ID: 16619524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple abnormalities detected by dye reversal genomic microarrays in prostate cancer: a much greater sensitivity than conventional cytogenetics.
    Pettus JA; Cowley BC; Maxwell T; Milash B; Stephenson RA; Rohr LR; Hoff C; Brothman AR
    Cancer Genet Cytogenet; 2004 Oct; 154(2):110-8. PubMed ID: 15474145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic analysis of prostatic adenocarcinomas from screening studies : early cancers may contain aggressive genetic features.
    Alers JC; Krijtenburg PJ; Vis AN; Hoedemaeker RF; Wildhagen MF; Hop WC; van Der Kwast TT; Schröder FH; Tanke HJ; van Dekken H
    Am J Pathol; 2001 Feb; 158(2):399-406. PubMed ID: 11159178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetics of prostate cancer.
    Nupponen NN; Visakorpi T
    Microsc Res Tech; 2000 Dec; 51(5):456-63. PubMed ID: 11074616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic analysis of prostate carcinoma specimens obtained via ultrasound-guided needle biopsy may be of use in preoperative decision-making.
    Teixeira MR; Ribeiro FR; Eknaes M; Waehre H; Stenwig AE; Giercksky KE; Heim S; Lothe RA
    Cancer; 2004 Oct; 101(8):1786-93. PubMed ID: 15386312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical dissection of genetic pathways involved in prostate carcinogenesis.
    Ribeiro FR; Diep CB; Jerónimo C; Henrique R; Lopes C; Eknaes M; Lingjaerde OC; Lothe RA; Teixeira MR
    Genes Chromosomes Cancer; 2006 Feb; 45(2):154-63. PubMed ID: 16235241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
    Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
    Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A copy number gain of the 6p arm is linked with advanced hepatocellular carcinoma: an array-based comparative genomic hybridization study.
    Chochi Y; Kawauchi S; Nakao M; Furuya T; Hashimoto K; Oga A; Oka M; Sasaki K
    J Pathol; 2009 Apr; 217(5):677-84. PubMed ID: 19097070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal aberrations in prostate cancer xenografts detected by comparative genomic hybridization.
    Laitinen S; Karhu R; Sawyers CL; Vessella RL; Visakorpi T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):66-73. PubMed ID: 12203791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic changes in colorectal carcinoma tumors with liver metastases analyzed by comparative genomic hybridization and DNA ploidy.
    Nakao K; Shibusawa M; Ishihara A; Yoshizawa H; Tsunoda A; Kusano M; Kurose A; Makita T; Sasaki K
    Cancer; 2001 Feb; 91(4):721-6. PubMed ID: 11241239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cytogenetics of primary breast cancer by CGH.
    Tirkkonen M; Tanner M; Karhu R; Kallioniemi A; Isola J; Kallioniemi OP
    Genes Chromosomes Cancer; 1998 Mar; 21(3):177-84. PubMed ID: 9523192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
    Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
    Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic changes in localized prostate cancer of Japanese patients shown by comparative genomic hybridization.
    Kasahara K; Taguchi T; Yamasaki I; Kamada M; Shuin T
    Cancer Genet Cytogenet; 2005 May; 159(1):84-8. PubMed ID: 15860364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.